---
title: "Why Did Curis (CRIS) Stock Soar After Hours?"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291511060.md"
description: "Curis (CRIS) shares surged 8.51% after hours to $0.46 following confirmation that its approved reverse stock split will take effect on Thursday, July 6. The split, ranging from 1-for-5 to 1-for-25, aims to restore compliance with Nasdaq's minimum bid price rule. Despite the after-hours gain, the stock closed regular trading down 19.15%, reflecting a significant 75.88% decline over the past year."
datetime: "2026-07-02T07:12:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291511060.md)
  - [en](https://longbridge.com/en/news/291511060.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291511060.md)
generator: "portal-rs"
---

# Why Did Curis (CRIS) Stock Soar After Hours?

**Curis, Inc.** (NASDAQ:CRIS) shares surged 8.51% to $0.46 after the bell on Wednesday, after the Massachusetts-based biotechnology company confirmed its previously approved reverse stock split will take effect on Thursday.

## Split Aims To Restore Nasdaq Compliance

According to Curis’s Wednesday filing with the **Securities and Exchange Commission**, the split becomes effective at 5:00 p.m. ET with split-adjusted trading beginning Jul. 6.

The stock will keep trading under the ticker “CRIS.” 

Shareholders approved the split, ranging from 1-for-5 to 1-for-25, at a Jun. 25 special meeting, aimed at helping Curis regain compliance with Nasdaq’s $1.00 minimum bid price rule.

## Trading Metrics, Technical Analysis

Curis has a market capitalization of $16.52 million, a 52-week high of $2.01 and a 52-week low of $0.18.

The Relative Strength Index (RSI) of CRIS stands at 48.76.

The biotech stock has dropped 75.88% over the past 12 months.

Currently, CRIS is trading at about 13% of its 52-week range, near the lower end of its annual trading band.

**Price Action:** The stock closed the regular session down 19.15% at $0.42, according to Benzinga Pro.

**Benzinga’s Edge Stock Rankings** indicate that CRIS has a negative price trend across all time frames.

*Photo Courtesy: Zakharchuk on Shutterstock.com*

**Disclaimer:** This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

 **Read Also: Vimeo Owner Bending Spoons (BSP) Stock Is Trending After Hours: Here's What You Should Know**

### Related Stocks

- [CRIS.US](https://longbridge.com/en/quote/CRIS.US.md)

## Related News & Research

- [NeuroSense Therapeutics to Enact 1-for-20 Reverse Share Split on Nasdaq](https://longbridge.com/en/news/298504880.md)
- [Compass Therapeutics, Inc. (NASDAQ:CMPX) Given Average Recommendation of "Moderate Buy" by Brokerages](https://longbridge.com/en/news/298407524.md)
- [John Smither Sells 1,600 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) Stock](https://longbridge.com/en/news/298505266.md)
- [NeuroSense Therapeutics effects 1-for-20 reverse stock split on Sept. 14, 2026](https://longbridge.com/en/news/298501385.md)
- [Candel Therapeutics, Inc. (NASDAQ:CADL) Given Average Recommendation of "Moderate Buy" by Brokerages](https://longbridge.com/en/news/298423186.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**